Patent · US Active

Thiazole derivatives

US7371751B2 · kind B2 · utility

4Cited by

4References

18Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Matthias Nettekoven · Weil am Rhein, DE
Stephan Roever · Inzlingen, DE

Key dates

Filing date	Dec 3, 2004
Grant date	May 13, 2008
Priority date	—
Expiry date	Jun 6, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I)wherein R1, R2, R3 and R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, including obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.